These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14597986)

  • 1. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans.
    Reiter R; Derhaschnig U; Spiel A; Keen P; Cardona F; Mayr F; Jilma B
    Thromb Haemost; 2003 Nov; 90(5):898-903. PubMed ID: 14597986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cleaved peptide of PAR1 is a more potent stimulant of platelet-endothelial cell adhesion than is thrombin.
    Claytor RB; Michelson AD; Li JM; Frelinger AL; Rohrer MJ; Garnette CS; Barnard MR; Krueger LA; Furman MI
    J Vasc Surg; 2003 Feb; 37(2):440-5. PubMed ID: 12563219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of adenosine diphosphate in the course of thrombin signal transmission].
    Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel 33-kDa Ser/Thr kinase that phosphorylates the cytoplasmic tail of protease-activated receptor 1 (thrombin receptor) in human platelets.
    Ido M; Hayashi T; Gabazza EC; Suzuki K
    Thromb Haemost; 2000 Apr; 83(4):617-21. PubMed ID: 10780327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Protease-Activated Receptor (PAR1) Reduces Activation of the Endothelium, Coagulation, Fibrinolysis and Inflammation during Human Endotoxemia.
    Schoergenhofer C; Schwameis M; Gelbenegger G; Buchtele N; Thaler B; Mussbacher M; Schabbauer G; Wojta J; Jilma-Stohlawetz P; Jilma B
    Thromb Haemost; 2018 Jul; 118(7):1176-1184. PubMed ID: 29864779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
    Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
    Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet protease-activated receptor 1 and membrane expression of P-selectin in pulmonary arterial hypertension.
    Maeda NY; Carvalho JH; Otake AH; Mesquita SM; Bydlowski SP; Lopes AA
    Thromb Res; 2010 Jan; 125(1):38-43. PubMed ID: 19447475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity.
    Dicker IB; Pedicord DL; Seiffert DA; Jamieson GA; Greco NJ
    Thromb Haemost; 2001 Oct; 86(4):1065-9. PubMed ID: 11686325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
    Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
    Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist.
    Hawes BE; Zhai Y; Hesk D; Wirth M; Wei H; Chintala M; Seiffert D
    Eur J Pharmacol; 2015 Sep; 762():221-8. PubMed ID: 26022529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin.
    Schlagenhauf A; Schweintzger S; Birner-Gruenberger R; Leschnik B; Muntean W
    Platelets; 2010; 21(8):641-7. PubMed ID: 20807173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated reactivity of whole blood neonatal platelets to various agonists.
    Pietrucha T; Wojciechowski T; Greger J; J drzejewska E; Nowak S; Chrul S; Golański J; Watala C
    Platelets; 2001 Mar; 12(2):99-107. PubMed ID: 11297038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Pro-Thrombotic Platelet Activity Associated with Thrombin/PAR1-Dependent Pathway Disorder in Patients with Secondary Progressive Multiple Sclerosis.
    Dziedzic A; Miller E; Bijak M; Przyslo L; Saluk-Bijak J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
    Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanizing the Protease-Activated Receptor (PAR) Expression Profile in Mouse Platelets by Knocking PAR1 into the Par3 Locus Reveals PAR1 Expression Is Not Tolerated in Mouse Platelets.
    French SL; Paramitha AC; Moon MJ; Dickins RA; Hamilton JR
    PLoS One; 2016; 11(10):e0165565. PubMed ID: 27788223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
    Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aprotinin and recombinant variants on platelet protease-activated receptor 1 activation.
    Day JR; Haskard DO; Taylor KM; Landis RC
    Ann Thorac Surg; 2006 Feb; 81(2):619-24. PubMed ID: 16427862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.